Fort Worth, TX, United States of America

Aleksa Jovanovic

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Memphis, TN (US) (2023)
  • Fort Worth, TX (US) (2015 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovations of Aleksa Jovanovic

Introduction

Aleksa Jovanovic is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of active agent delivery systems, holding a total of 16 patents. His work focuses on developing innovative solutions that enhance the efficacy of drug delivery.

Latest Patents

One of his latest patents is a dissolvable gel-forming film designed for the delivery of active agents. This invention comprises a water-soluble cellulose ether, a hydrophilic rheological modifying agent, and an active proteolytic enzyme or other drug substances. The gel-forming film has a water content of less than 15% w/w and is capable of forming a hydrogel when it comes into contact with water or other aqueous mediums. This technology achieves the stable delivery of proteolytic enzymes to the desired site of action, ensuring uniform delivery of the enzymes.

Career Highlights

Throughout his career, Jovanovic has worked with prominent companies such as Smith & Nephew Pte. Limited and Smith & Nephew Orthopaedics AG. His experience in these organizations has allowed him to refine his skills and contribute to advancements in medical technology.

Collaborations

Some of his notable coworkers include Lei Shi and Eric Roche. Their collaboration has likely fostered an environment of innovation and creativity, leading to the development of groundbreaking technologies.

Conclusion

Aleksa Jovanovic's contributions to the field of active agent delivery systems exemplify his dedication to innovation. His patents reflect a commitment to improving medical technologies and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…